G Square Healthcare PE
G Square Healthcare Private Equity LLP is a London-based pan-European private equity firm founded in 2008 by Laurent Ganem, specialising exclusively in healthcare investments across buy-out and growth transactions in the mid-market. The firm focuses on companies with enterprise values of EUR 50-200 million and provides EUR 30-60 million of equity per deal. Registered in England and Wales and authorised and regulated by the UK Financial Conduct Authority under firm reference number 605527.
Key facts
Recent exits
Coverage notes
6 funds tracked, 29 portfolio companies (17 active · 12 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
29 companiesFunds & portfolio
Every fund G Square Healthcare PE has raised, with its portfolio companies. Hand-checked from public filings.
G Square Pharmacy2U Continuation FundSecondaries2026 · 0yr€580M1 active
G Square Capital CVBuyout2022 · 4yr€500M2 active · 1 realized
Unrealized
2 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare |  UK | 2022 | |
| Healthcare | UK | 2022 |
UK· Entry 2022UK· Entry 2022G Square Capital IVBuyout2021 · 5yr€800M3 active
G Square Capital IIIBuyout2020 · 6yr€460M8 active · 3 realized
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare |  United States | 2022 | |
| Healthcare | UK | 2021 | |
| Healthcare |  France | 2019 | |
| Healthcare | UK | 2021 | |
| HealthTech | Israel | 2020 | |
| Healthcare | UK | 2020 | |
| Education | France | 2021 | |
| Healthcare | UK | 2019 |
United States· Entry 2022UK· Entry 2021France· Entry 2019UK· Entry 2021UK· Entry 2020France· Entry 2021UK· Entry 2019Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare |  Italy | 2021 | 2024 | Trade Sale | – | ||
| HealthTech | France | 2020 | 2026 | Trade Sale | – | ||
| HealthTech | UK | 2018 | 2026 | Secondary | – |
G Square Capital IIBuyout2017 · 9yr€322M3 active · 3 realized
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare | France | 2016 | |
| Healthcare | France | 2017 | |
| Healthcare |  Norway | 2016 |
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare |  Netherlands | 2015 | 2022 | Continuation Vehicle | – | ||
| MedTech |  Belgium | 2017 | 2024 | Trade Sale | – | ||
| Healthcare | UK | 2017 | 2022 | Continuation Vehicle | – |
G Square Capital IBuyout2011 · 15yr€192M0 active · 5 realized
Realized
5 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare | UK | 2014 | 2022 | Continuation Vehicle | – | ||
| Healthcare |  Germany | 2011 | 2015 | Trade Sale | – | ||
| Healthcare |  Finland | 2012 | 2017 | Trade Sale | – | ||
| Healthcare |  Spain | 2009 | 2017 | Trade Sale | – | ||
| Healthcare |  Switzerland | 2013 | 2015 | MBO | – |
Saved GPs appear in your watchlist, one click from your workspace.
About G Square Healthcare PE
G Square Healthcare Private Equity is one of Europe's only pure-play healthcare PE specialists with approximately $4.0 billion (~€3.7 billion) of assets under management as of December 2024, headquartered in London. The firm was founded in 2008 as a UK healthcare-specialist PE firm and operates as a partner-owned Limited Liability Partnership with approximately 32 professionals, a UN PRI signatory since 2012. G Square raised an approximately €500 million continuation vehicle in 2024 to extend control of two legacy funds.
Investment thesis
G Square Healthcare deploys capital through approximately five funds (GSC I, II, III, IV plus a continuation vehicle), targeting mid-market control buyouts in healthcare with hands-on growth acceleration and buy-and-build. Sector focus spans healthcare services, medical products and devices, medtech distribution, digital health, diagnostics and pharma services. Geographic deployment is pan-European core (UK, Benelux, Italy, Nordics, DACH) with selective global expansion of portfolio companies. The platform pairs deep sector knowledge with operational buy-and-build expertise.
Recent activity
Recent realised exits include medtech distribution (2024). Recent acquisitions include biomaterials and orthopaedics (2025), surgical fluid management (2026) and healthcare services pharmacy (2026). The platform continues active deployment across the pan-European healthcare mandate. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
United Kingdom·€3.2B
United Kingdom·€3.5B
United Kingdom·€3.5B
United Kingdom·€3.0B
United Kingdom·€3.0B
United Kingdom·€2.9B
United Kingdom·€2.8B
United Kingdom·€4.1B
United Kingdom·€2.3B
United Kingdom·€2.3B
United Kingdom·€2.3B
United Kingdom·€4.4BGet the full picture on G Square Healthcare PE.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in